Volume 20 - Number 7 - July 2012

Clinical Geriatrics

Physician's Perspective
Physician's Perspective
Inoperable?-A Status Not Written in Stone
07/18/2012
Steven R. Gambert, MD, AGSF, MACP
As new advances in medicine become a reality, it is imperative that clinicians re-evaluate conditions previously labeled as inoperable or untreatable.
07/18/2012
Washington Update
Washington Update
Washington Update - July 2012
07/18/2012
According to many pundits, the House vote was a largely symbolic move, an opportunity for Republicans to underscore their opposition.
07/18/2012
First Report®
First Report®
American Society of Consultant Pharmacists (ASCP) Spring Conference and Exhibition
07/18/2012
American Society of Consultant Pharmacists (ASCP) Spring Conference and Exhibition: May 21-23, 2012; Anaheim, CA
07/18/2012
First Report®
First Report®
American Society of Clinical Oncology (ASCO) 2012 Annual Meeting
07/18/2012
American Society of Clinical Oncology (ASCO) 2012 Annual Meeting: May 1-5, 2012; Chicago, IL
07/18/2012
Ask the Expert
Ask the Expert
Appropriate Use of Dabigatran in Geriatric Patients: An Interview With Eugene Yang, MD
07/18/2012
Serious side effects have been associated with dabigatran use, in particular, bleeding complications.
07/18/2012
Case Report
Case Report
Reversible Dementia From Corticosteroid Therapy
07/18/2012
Gabriele Cipriani, MD; Lucia Picchi, PsyD; Marcella Vedovello, MD; Angelo Nuti, MD
Corticosteroids are given for a variety of common illnesses on both an outpatient and inpatient basis.
07/18/2012
Case Report
Case Report
Fatal Pulmonary Toxicity After a Short Course of Amiodarone Therapy
07/18/2012
Magali-Noelle Pfeil, MD; Peter Vollenwider, MD; Jean-William Fitting, MD
Whenever possible, low-dose amiodarone should be used as briefly as possible because there are no adequate predictors of pulmonary toxicity.
07/18/2012
Pain in Older Adults
Pain in Older Adults
Opioids With Abuse-Deterrent Technologies: What Role Do They Play in Managing Chronic Pain in Older Adults?
07/18/2012
Manney Carrington Reid, MD, PhD; Andrew Behm, PharmD; Katie M. Low, PharmD; Michele Medina, PharmD, BCPS
The FDA is taking an aggressive stance to reduce the abuse, misuse, and diversion of prescription opioids.
07/18/2012